Sarah Speight
Key details
- Title: Senior Writer
- Email:sspeight@lifesciencesipreview.com
- Telephone: +44 (0)20 330 18210
Total results: 187
Articles by Sarah Speight
Pharma
Delaware judge denies pharma giant’s request for injunction on rivals’ generic of Entresto | Novartis ‘unlikely to succeed’ in proving infringement | Lawsuit is one of several attempts to preserve exclusivity of the drug ahead of patent expiry and US price caps. 13 August 2024
Americas
The appointee represents a diverse range of tech clients, including in medtech and life sciences and will now lead the firm’s California offices. 25 July 2024
Europe
Paris Central Division issues its first revocation judgment in dispute brought by Meril subsidiaries in Italy, Germany and India | Decision means infringement action by Edwards can resume at Munich Local Division | Damages worth €8m ($8.7m) | Gide, Marks & Clerk, Potter Clarkson among representatives. 23 July 2024
Americas
List compiled by sister title features peer-reviewed IP lawyers from across six continents | 2024 edition “most comprehensive and rigorous” to date, says rankings editor | Data reveals gender ratio and practice area concentration by continent. 2 July 2024
Americas
Magistrate stand-in not authorised to answer jury questions, says eleventh circuit in precedential opinion | Florida judge left to catch flight before verdict given | Dispute between shrimp breeders concerns “unique” breeding method. 20 June 2024
Careers
ABG IP says the promotions recognise staff performance, improve gender equality and lower the average age among partners, and secure its values and position in the market. 4 June 2024
Pharma
US Senate committee accuses drug companies of ‘gaming’ the patent system | Industry representatives interrogated during hearing | ‘Playing games with patents has to stop’, says one Senator. 23 May 2024
Americas
New recruit, who joins the firm’s Orange County office, brings patent experience in genomics, immunology and gene editing technologies. 14 May 2024
Pharma
AstraZeneca, GSK and Teva among manufacturers accused of “improper” submission of patents | More than 300 patents targeted in second wave of challenges by Federal Trade Commission | ‘Junk patents’ block competition and ramp up prices unfairly, says FTC chair. 2 May 2024
Americas
New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth “billions of dollars”, is filed as UK trial kicks off between Moderna, Pfizer and BioNTech. 26 April 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.